Concerns/Issues about Results and/or Conclusions
- Patient undergoing colectomy because of ulcerative colitis had a very high rate of surgical complications in clinical practice conditions1/24/2022 0:00
- Anti TNF therapy in elderly people in IBD: A multicentre survey1/24/2022 0:00
- Mucosal healing in ulcerative colitis patients treated with azathioprine and its influence on quality of life1/24/2022 0:00
- Atherosclerosis in patients with infammatory bowel diseases: Evaluation of several candidate factors for early detection1/24/2022 0:00
- Thiopurine-induced myelotoxicity in inflammatory bowel disease (IBD): A multicenter study1/24/2022 0:00
- Effectiveness of infliximab after adalimumab failure in Crohn’s disease1/24/2022 0:00
- Effect of anti-TNF alpha treatment on short-term post-operative complications in patients with inflammatory bowel disease: An Italian single center experience1/24/2022 0:00
- Early response to combined oral and topical mesalazine (PENTASA®) for ulcerative colitis: Post-hoc analysis of efficacy at two weeks in the PINCE trial1/24/2022 0:00
- Smokers with inflammatory bowel disease have low nicotine dependence1/24/2022 0:00
- Infliximab in steroid-refractory pediatric ulcerative colitis: Predictors of response in a prospective multicenter study1/24/2022 0:00
- Audit of prevention of opportunistic infections in immunosuppressed patients with IBD: How close are we to ECCO guidelines?1/24/2022 0:00
- Azathioprine and smoking habits are the only predictors of severe endoscopic postoperative recurrence in Crohn’s disease: Results of a prospective study1/24/2022 0:00
- Impact of medical treatments on the clinical course of inflammatory bowel diseases (IBD): Data from a French regional survey1/24/2022 0:00
- Skin complications during therapy with anti-TNFa preparations: Experience of a single centre1/24/2022 0:00
- Long-term durability of response to adalimumab treatment in Crohn’s disease1/24/2022 0:00
- Effectiveness of adalimumab in the treatment of extraintestinal manifestations of Crohn’s disease1/24/2022 0:00
- Patient response to anti-TNF dose escalation in Crohn’s disease using health claims data1/24/2022 0:00
- Mesenchymal stem cells transplantation decreases relapse development risk in patients with ulcerative colitis1/24/2022 0:00
- Recommendations from available standards on organizational aspects for the management of inflammatory bowel disease by specialist nurses1/24/2022 0:00
- Predicting outcome of infliximab treatment in Crohn’s disease1/24/2022 0:00
- Is methotrexate for inflammatory bowel diseases underused in clinical practice?1/24/2022 0:00
- Long-term results with mesalazine therapy in patients persistent with therapy at outset1/24/2022 0:00
- Local infliximab treatment in ileocolonic anastomotic Crohn’s disease recurrence: Efficacy at 12 months follow-up1/24/2022 0:00
- The benefit of a tailored patient preference intervention in adherence to 5-ASA medication in ulcerative colitis: Results from a randomised controlled trial1/24/2022 0:00
- Endoscopic outcome of medium term adalimumab therapy in patients with Crohn’s disease. National data from Hungary1/24/2022 0:00
- Mucosal healing with methotrexate in Crohn’s disease: A prospective comparative study with azathioprine and infliximab1/24/2022 0:00
- UK inflammatory bowel disease audit: IBD nurse correlations between 2006 and 20081/24/2022 0:00
- A multidisciplinary virtual biologic clinic: Is it worthwhile?1/24/2022 0:00
- Adalimumab versus Infliximab clinical comparision: Longitudinal study1/24/2022 0:00
- Efficacy and safety of chronic hepatitis C treatment with pegylated interferon alpha 2a/b and ribavirin in patients with inflammatory bowel disease1/24/2022 0:00
- Early post-operative endoscopic recurrence in Crohn’s disease in an Italian multicentric cohort1/24/2022 0:00
- Long term efficacy of granulocyte-monocyte-apheresis in ulcerative colitis. The Italian Registry of Therapeutic Apheresis1/24/2022 0:00
- Evaluation of potential correlations between serum adalimumab concentration and remission in patients with Crohn’s disease in CLASSIC I and II1/24/2022 0:00
- Fecal calprotectin may differentiate between IBS and IBD symptomes in IBD patients1/24/2022 0:00
- Paradoxical effect of IL13 blockage in inflamed colon mucosa of ulcerative colitis patients1/24/2022 0:00
- Emerging safety profile of vedolizumab: A novel, selective integrin inhibitor for treatment of IBD1/24/2022 0:00
- Certolizumab pegol demonstrates efficacy in maintaining response and remission in patients with active Crohn’s disease regardless of their immunosuppressant treatment status at entry to the PRECiSE 2 study1/24/2022 0:00
- Immunomodulatory treatment reduces the need for ileocecal resection in Crohn’s disease1/24/2022 0:00
- Predictors of suboptimal medication adherence in IBD patients: A single Australian tertiary centre experience1/24/2022 0:00
- Efficacy of once-daily versus twice-daily mesalazine (PENTASA®): Sub-analysis of the left-sided colitis population in the randomised PODIUM trial1/24/2022 0:00
- Use of immunosuppressants and anti-TNF for inflammatory bowel diseases (IBD) in current practice: Data from a French regional survey1/24/2022 0:00
- Adalimumab therapy in ulcerative colitis patients with previous colectomy1/24/2022 0:00
- Does cognitive behavioural therapy (CBT) improve outcomes in IBD? Feasibility, patient acceptance and preliminary results1/24/2022 0:00
- Osteoporosis prophylaxis in IBD: Still a neglected field?1/24/2022 0:00
- What’s cheapest, intravenous iron sucrose- or intravenous iron carboxymaltose treatment in IBD-patients? It depends on the economic evaluation perspective!1/24/2022 0:00
- Clinical benefit of dietary advice in ulcerative colitis (UC): Results of a pilot study1/24/2022 0:00
- Comparative efficiency of current strategies in the treatment for ulcerative colitis severe relapses1/24/2022 0:00
- Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? A subgroup analysis of a prospective multicentre online-based trial1/24/2022 0:00
- Bone mineral density assessment in patients with inflammatory bowel diseases1/24/2022 0:00
- What influences persistence with mesalazine therapy? Results from a large pharmacy database1/24/2022 0:00